According to our research analysis, North America CRISPR Gene Editing Market 2021-2031 is projected to grow by 24.4% annually in the forecast period and reach USD 5,976.7 million by 2031, driven by the rising demand for better food and medical products, innovative advancement in gene therapy supported by the continued investments in healthcare, rising geriatric population and the increasing genomic and chronic diseases, and the development of rapid CRISPR-based POC tests amid COVID-19 pandemic.
Highlighted with 28 tables and 50 figures, this 118-page report North America CRISPR Gene Editing Market 2021-2031 by Offering (Products, Services), Application (Biomedical, Agriculture, Industrial, Others), End User (Pharmaceutical Companies, Biotechnology Companies, Academic Institutions & Research Centers, Others), and Country: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire North America CRISPR Gene Editing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year.
In-depth qualitative analyses include identification and investigation of the following aspects:
- Market Structure
- Growth Drivers
- Restraints and Challenges
- Emerging Product Trends & Market Opportunities
- Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America CRISPR Gene Editing market in every aspect of the classification from perspectives of Offering, Application, End User, and Country.
Based on Offering, the North America market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.
CRISPR Products
- Kits & Enzymes
- Vector-Based Cas9
- DNA-Free Cas9
Based on Application, the North America market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.
Biomedical Research & Therapy
- Gene Therapy
- Drug Discovery
- Diagnostics
- Other Biomedical Applications
- Agriculture
- Industrial Use
Get Free Sample Report of North America CRISPR Gene Editing Market: –
https://kenresearch.com/sample-report.php?Frmdetails=NTMyMjkx
For each key country, detailed analysis and data for annual revenue (USD mn) are available for 2021-2031. The breakdown of key national markets by Offering, Application, and End User, over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
- Selected Key Players:
- Abcam, Inc.
- Agilent Technologies, Inc.
- Applied StemCell, Inc.
- Caribou Biosciences, Inc.
- Cellecta, Inc.
For More Information, refer to below link: –
North America CRISPR Gene Editing Market Growth Rate
Related Reports:
Follow Us –
LinkedIn | Instagram | Facebook | Twitter | YouTube
Contact Us: –
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249
